The ischemic penumbra — neurons damaged but not killed by stroke — may remain viable for years in a metabolically compromised, "idling" state. HBOT dissolves oxygen directly into plasma under pressure, bypassing hemoglobin and reaching tissue that restricted circulation cannot adequately supply. Researchers are investigating whether restoring oxygen to penumbral neurons can reactivate their function and allow them to re-engage neuroplastic pathways that have been dormant.

Stroke disrupts the microvascular architecture of affected brain regions — even when neurons survive, the blood supply that sustains them may be permanently compromised. HBOT stimulates angiogenesis — new capillary formation — in hypoxic tissue. In chronic stroke patients, this may help rebuild the vascular infrastructure that stroke-affected regions need for sustained neurological function, potentially enabling improvements that were impossible without adequate circulation.

Research at the University of Pennsylvania documented an 800% increase in circulating stem cells following HBOT. In stroke recovery, these mobilized stem cells may migrate to affected brain regions and support neural repair — differentiating into neurons, astrocytes, and endothelial cells needed for both neurological function and vascular reconstruction. The Sagol Center has proposed this mechanism as part of the explanation for late-stage improvements documented in chronic stroke patients.

The brain retains neuroplastic capacity — the ability to reorganize and form new connections — far longer than the six-month plateau model suggests. But neuroplasticity requires metabolic conditions: adequate oxygen, reduced inflammation, and energy for the active remodeling process. By improving all three simultaneously, HBOT may create the biological environment that allows neuroplastic reorganization to resume in patients who have plateaued on conventional rehabilitation.

Chronic neuroinflammation — persistent immune activation in and around stroke-affected tissue — is a significant barrier to late-stage recovery. Inflammatory cytokines and microglial activation suppress the neuroplastic processes needed for functional recovery. HBOT has documented anti-neuroinflammatory effects including reductions in microglial activation and pro-inflammatory signaling in neural tissue — potentially removing one of the key biological obstacles to chronic stroke recovery.

Neurons deprived of adequate oxygen shift into metabolic hibernation — reducing function to conserve energy. Mitochondrial dysfunction in these hypoxic neurons further impairs their capacity to produce the energy needed for repair and functional restoration. HBOT's oxygen surge supports mitochondrial function in compromised neurons, potentially rescuing cells from metabolic hibernation and restoring the energy production needed for active neuroplastic remodeling.